Ming Zhao: Clinical Trials

2 trials sponsored by Ming Zhao, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Unknown 1

Follow Ming Zhao: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma
TACE, RFA - Hepatocellular Carcinoma, Chemoembolization, Therapeutic
Phase 3CompletedMing Zhao2412015-05-012026-03-31
Combine TACE and RFA Versus TACE Alone for HCC With PVTT
TACE, RFA, pirarubicin,mitomycin and lobaplatin - Hepatocellular Carcinoma
Phase 3UnknownMing Zhao2402014-10-012016-04-14

Conditions studied

Carcinoma, Hepatocellular (2)

Interventions

Chemoembolization, Therapeutic (1)  ·  Cytotoxins (1)  ·  Mitomycin (1)  ·  lobaplatin (1)  ·  pirarubicin (1)

Countries

China (2)

Results publications

PMID 42530948